Article Information
History
- September 29, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Leen N Vanheer, MD1,*,
- Jordache Ramjith, PhD2,*,
- Almahamoudou Mahamar, PhD3,*,
- Merel J Smit, MD2,
- Kjerstin Lanke2,
- Michelle E Roh, PhD4,
- Koualy Sanogo, MD3,
- Youssouf Sinaba, MD3,
- Sidi M. Niambele, PharmD3,
- Makonon Diallo, MD3,
- Seydina O Maguiraga, MD3,
- Sekouba Keita, MS3,
- Siaka Samake, PharmD3,
- Ahamadou Youssouf PharmD3,
- Halimatou Diawara, MD3,
- Sekou F. Traore, PhD3,
- Roly Gosling, MD5,6,
- Joelle M Brown, PhD6,
- Chris Drakeley, PhD1,
- Alassane Dicko, MD3,†,
- Will Stone, PhD†,1 and
- Teun Bousema, PhD2,†,#
- 1Department of Infection Biology, London School of Hygiene & Tropical Medicine, London, UK, WC1E7HT
- 2Department of Medical Microbiology and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands
- 3Malaria Research and Training Centre, Faculty of Pharmacy and Faculty of Medicine and Dentistry, University of Sciences Techniques and Technologies of Bamako, Bamako, Mali
- 4Institute for Global Health Sciences, University of California, San Francisco, CA, USA
- 5Department of Disease Control, London School of Hygiene and Tropical Medicine, London UK
- 6Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA
- ↵#Corresponding author: Teun Bousema: teun.bousema{at}radboudumc.nl
Posted September 29, 2024.
The transmission blocking activity of artemisinin-combination, non-artemisinin, and 8-aminoquinoline antimalarial therapies: a pooled analysis of individual participant data
